Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT05619653Phase 3Active Not Recruiting
Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19
COVID-19 Associated Cardiac InvolvementExercise IntoleranceLeft Ventricular Dysfunction+6 more
PrincipalinvestigatorStart date: 2022-12-12
NCT01236807Not ApplicableCompleted
MR INFORM - MR Perfusion Imaging to Guide Management of Patients With Stable Coronary Artery Disease
Coronary Artery DiseaseMyocardial IschaemiaStable Angina
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Valentina Puntmann, MD, PhD

Goethe University Frankfurt

Very Similar
1 trials

Shared therapeutic areas:

COVID-19 Associated Cardiac InvolvementExercise IntoleranceInflammatory cardiovascular involvement due to COVID-19, defined by Cardiovascular magnetic resonance imaging+7 more

Worked with same sponsors:

Alcedis GmbHBayer+1 more
Collaborated on 1 trial
Similarity Score104%

Harry Hemingway, FRCP

University College, London

Related
12 trials

Shared therapeutic areas:

Angina, StableCoronary Artery Disease
Similarity Score5%

Bon-Kwon Koo, MD, PhD

Seoul National University Hospital

Related
18 trials

Shared therapeutic areas:

Coronary Artery DiseaseAngina, Stable
Similarity Score5%

Russell Esterline

AstraZeneca

Related
11 trials

Shared therapeutic areas:

Coronary Artery DiseaseMyocardial Ischaemia
Similarity Score5%

Jean-Claude Tardif, MD

Montreal Heart Institute

Related
13 trials

Shared therapeutic areas:

Coronary Artery DiseaseVascular Inflammation
Similarity Score5%

Jiyan Chen, M.D.

Guangdong Provincial People's Hospital

Related
4 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score2%

Amir Lerman, MD

Mayo Clinic

Related
15 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score2%

Zesheng Xu, M.D.

Cangzhou Central Hospital

Related
2 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score2%

Shubin Qiao, M.D.

Chinese Academy of Medical Sciences, Fuwai Hospital

Related
2 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score2%

Christelle Haziza, PhD

Philip Morris Products S.A.

Related
27 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05619653Phase 3PrincipalInvestigator

Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19

COVID-19 Associated Cardiac InvolvementExercise IntoleranceLeft Ventricular Dysfunction+6 more
Active Not Recruiting
NCT01236807Not ApplicablePrincipalInvestigator

MR INFORM - MR Perfusion Imaging to Guide Management of Patients With Stable Coronary Artery Disease

Coronary Artery DiseaseMyocardial IschaemiaStable Angina
Completed

All 2 trials loaded